GlobeNewsWire
10 Jul 2026, 00:30 UTC · 19w ago
Ryoncil® Delivers Net Revenue of US$36M for the Fourth Quarter Ended 30 June 2026
Impact · against what's priced in
Mesoblast's reported Ryoncil revenue of $115M for the fiscal year and the securing of a new five-year credit facility significantly improve the company's financial stability and growth profile. This combination of exceeding initial revenue projections and reducing the need for dilutive financing provides a strong positive catalyst for the stock.
- MSB+0.80
No priced-in read yet





